ResMed Inc. logo

ResMed Inc.

RMD | NYSE
Chart Builder DCF Calculator
$224.56
+$0.95 (+0.42%)
Sep 22, 2026, 2:37 PM ET · Market open

Market Data

Market Cap
$32.44B
Enterprise Value
$31.79B
Beta
0.77
Average Volume
1.53M
Shares Outstanding (Diluted)
144.98M
Shares Change YoY
-1.4%
Institutional Ownership
66.71%
Exchange
NYSE
ISIN
US7611521078

Price Performance

Price Change 1M
-3.2%
Price Change 3M
16.9%
Price Change 6M
-1.2%
Price Change YTD
-8.7%
Price Change 1Y
-18.5%
Price Change 3Y
63.7%
Price Change 5Y
-20.0%
1M CAGR (ann.)
5.8%
1Y CAGR (ann.)
-17.3%
5Y CAGR (ann.)
-4.1%
All-Time CAGR
13.4%

Valuation

PE Ratio
21.50
Forward PE
18.54
PEG Ratio
2.30
Forward PEG
2.14
PS Ratio
5.74
Forward PS
5.60
PB Ratio
4.93
P/FCF Ratio
11.23
P/Adj. FCF Ratio
11.98
P/OCF Ratio
10.25
EV/Sales
5.62
EV/EBIT
16.32
EV/EBITDA
14.81
EV/FCF
11.00
Earnings Yield
4.7%
FCF Yield
8.9%
Adj. FCF Yield
8.3%

Financial Health

Net Cash
$780.73M
Total Debt
$825.92M
Cash & Short-Term Investments
$1.47B
Total Assets
$8.97B
Current Ratio
3.10
Quick Ratio
2.42
Debt / Equity Ratio
0.13
Debt / EBITDA
0.38
Debt / FCF
0.29
OCF / Debt
3.82
Interest Coverage
65.20
Altman Z-Score
11.05
Piotroski F-Score
7

Margins & Profitability

Gross Profit Margin
61.2%
Operating Profit Margin
33.5%
EBITDA Margin
38.0%
Net Profit Margin
26.9%
FCF Margin
51.1%
Adj. FCF Margin
47.9%
SBC / Revenue
3.2%
SBC Impact (per share)
-6.3%

Returns

Return on Assets
17.0%
Return on Equity
23.9%
Return on Invested Capital
19.1%
Return on Capital Employed
25.0%
Return on Tangible Assets
27.2%

Historical Growth (CAGR)

Revenue CAGR 3Y
10.2%
Revenue CAGR 5Y
12.1%
Revenue CAGR 10Y
11.9%
EPS CAGR 3Y
19.5%
EPS CAGR 5Y
26.3%
EPS CAGR 10Y
15.5%
FCF CAGR 3Y
72.9%
FCF CAGR 5Y
36.0%
FCF CAGR 10Y
19.7%

Analyst Forecasts

Analyst Rating
Hold
Analyst Count
35
EPS Growth Next 3Y
11.8%
Revenue Growth Next 3Y
5.2%
Earnings Date
Oct 28, 2026
EPS Estimate (next Q)
$2.72
EPS Growth Est (next Q)
6.7%
Revenue Est (next Q)
$1.39B
Revenue Growth Est (next Q)
4.2%

Fair Value Estimates

Graham Number
$103.20
Graham Upside
-53.9%
Lynch Fair Value
$260
Lynch Upside
16.3%
Price Target
$242.70
Price Target Upside
8.5%

Cash Flow

Operating Cash Flow
$3.16B
Free Cash Flow
$2.89B
Adj. Free Cash Flow
$2.71B
FCF Per Share
$19.97
OCF Per Share
$21.82
OCF/S Ratio
55.8%

Income Statement

Revenue
$5.65B
Gross Profit
$3.46B
Operating Income
$1.89B
EBITDA
$2.15B
Net Income
$1.52B
EPS (Diluted)
$10.40
Revenue / Employee
$497.22K
Profit / Employee
$133.97K
Employees
11,370

Dividends

Annual Dividend
$2.46
Dividend Yield
1.10%
Payout Ratio
23.6%
FCF Payout Ratio
21.2%
Adj. FCF Payout Ratio
22.6%
Dividend Growth (YoY)
12.3%
Pay Frequency
Quarterly
Ex-Dividend Date
Aug 19, 2026

© 2026 bestshares.com. All rights reserved.